• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

速尿增加血浆氧嘌呤醇而不降低血清尿酸——一种复杂的药物相互作用:对临床实践的影响。

Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.

机构信息

Department of Medicine, University of Otago, Christchurch 8140, New Zealand.

出版信息

Rheumatology (Oxford). 2012 Sep;51(9):1670-6. doi: 10.1093/rheumatology/kes091. Epub 2012 Apr 26.

DOI:10.1093/rheumatology/kes091
PMID:22539486
Abstract

OBJECTIVE

To determine the effects of furosemide on serum urate (SU), plasma oxypurinol and urinary urate.

METHODS

Twenty-three cases with gout receiving furosemide and allopurinol were recruited. Twenty-three controls with gout receiving allopurinol but no diuretics were matched on age, gender, estimated glomerular filtration rate and allopurinol dose. SU, plasma oxypurinol and urinary urate were assessed on a single occasion. The effects of a single dose of furosemide 40 mg were examined in a separate group of 10 patients receiving allopurinol but not diuretic.

RESULTS

Cases had significantly higher SU and plasma oxypurinol compared with controls despite receiving similar doses of allopurinol. There was no difference in urinary urate excretion. There was a significant increase in area under the curve (AUC)(0-24) for oxypurinol after administration of furosemide 40 mg.

CONCLUSION

The interaction between allopurinol and furosemide results in increased SU and plasma oxypurinol. The exact mechanisms remain unclear but complex interactions that result in attenuation of the hypouricaemic effects of oxypurinol are likely.

TRIAL REGISTRATION

Australian New Zealand Clinical Trials Registry, www.anzctr.org.au, 12609000529246.

摘要

目的

确定速尿对血清尿酸(SU)、血浆氧嘌呤醇和尿尿酸的影响。

方法

招募了 23 例接受速尿和别嘌醇治疗的痛风患者,并与 23 例接受别嘌醇但未使用利尿剂的痛风对照者按年龄、性别、估计肾小球滤过率和别嘌醇剂量相匹配。在单次就诊时评估 SU、血浆氧嘌呤醇和尿尿酸。在接受别嘌醇但未使用利尿剂的 10 例患者中,单独检查了单次 40mg 速尿的作用。

结果

尽管接受了相同剂量的别嘌醇,但病例组的 SU 和血浆氧嘌呤醇明显高于对照组。尿尿酸排泄无差异。给予速尿 40mg 后,氧嘌呤醇的 AUC(0-24)显著增加。

结论

别嘌醇和速尿之间的相互作用导致 SU 和血浆氧嘌呤醇升高。确切的机制尚不清楚,但可能是复杂的相互作用导致氧嘌呤醇的降尿酸作用减弱。

试验注册

澳大利亚新西兰临床试验注册中心,www.anzctr.org.au,12609000529246。

相似文献

1
Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.速尿增加血浆氧嘌呤醇而不降低血清尿酸——一种复杂的药物相互作用:对临床实践的影响。
Rheumatology (Oxford). 2012 Sep;51(9):1670-6. doi: 10.1093/rheumatology/kes091. Epub 2012 Apr 26.
2
Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.在痛风管理中血清尿酸与血浆别嘌呤醇的关系:确定达到目标血清尿酸水平的最低血浆别嘌呤醇浓度。
Clin Pharmacol Ther. 2011 Sep;90(3):392-8. doi: 10.1038/clpt.2011.113. Epub 2011 Jul 27.
3
[Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].[别嘌醇与苯溴马隆联合治疗伴肾功能不全的痛风和高尿酸血症的疗效:氧嘌呤醇的动力学分析]
Nihon Jinzo Gakkai Shi. 2008;50(4):506-12.
4
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.别嘌醇和丙磺舒在痛风患者中的药代动力学和药效学相互作用。
J Rheumatol. 2011 May;38(5):904-10. doi: 10.3899/jrheum.101160. Epub 2011 Feb 1.
5
Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.痛风中髓过氧化物酶与尿酸氧化:对高尿酸血症临床后果的影响
Rheumatology (Oxford). 2014 Nov;53(11):1958-65. doi: 10.1093/rheumatology/keu218. Epub 2014 Jun 4.
6
Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.对于患有慢性肾病的痛风患者,可能需要更高的治疗性血浆氧嘌呤醇浓度。
J Clin Rheumatol. 2008 Feb;14(1):6-11. doi: 10.1097/RHU.0b013e318164dceb.
7
An audit of a therapeutic drug monitoring service for allopurinol therapy.别嘌醇治疗的治疗药物监测服务审核。
Ther Drug Monit. 2013 Dec;35(6):863-6. doi: 10.1097/FTD.0b013e318299920a.
8
Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment.别嘌醇与呋塞米在痛风治疗中不良药物相互作用的分子机制
Biochem Biophys Res Commun. 2014 Sep 12;452(1):157-62. doi: 10.1016/j.bbrc.2014.08.068. Epub 2014 Aug 21.
9
Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.别嘌醇剂量、氧嘌呤醇浓度与降尿酸反应的关系——寻找最小有效氧嘌呤醇浓度。
Clin Transl Sci. 2020 Jan;13(1):110-115. doi: 10.1111/cts.12686. Epub 2019 Sep 3.
10
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout.在成年男性痛风患者中进行的维那鲁胺(RDEA3170)和别嘌醇同时多次给药的药代动力学、药效学和耐受性。
J Clin Pharmacol. 2018 Sep;58(9):1214-1222. doi: 10.1002/jcph.1119. Epub 2018 May 7.

引用本文的文献

1
Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia.黄嘌呤醇在患有痛风和/或高尿酸血症的苗族成年人中的群体药代动力学、药效学和药物遗传学建模。
Br J Clin Pharmacol. 2023 Oct;89(10):2964-2976. doi: 10.1111/bcp.15792. Epub 2023 Jun 4.
2
The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics.尿酸转运体遗传变异对别嘌醇药代动力学的影响。
Clin Transl Sci. 2023 Mar;16(3):422-428. doi: 10.1111/cts.13460. Epub 2022 Nov 25.
3
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF.
达格列净可降低尿酸浓度,尿酸浓度是 DAPA-HF 不良结局的独立预测因子。
Eur J Heart Fail. 2022 Jun;24(6):1066-1076. doi: 10.1002/ejhf.2433. Epub 2022 Feb 6.
4
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study.痛风控制不佳的特征、合并症及潜在后果:一项保险理赔数据库研究
Rheumatol Ther. 2021 Mar;8(1):183-197. doi: 10.1007/s40744-020-00260-1. Epub 2020 Dec 7.
5
Risk factors for cutaneous reactions to allopurinol in Kinh Vietnamese: results from a case-control study.京族越南人使用别嘌醇后发生皮肤反应的危险因素:一项病例对照研究的结果
Arthritis Res Ther. 2020 Aug 3;22(1):182. doi: 10.1186/s13075-020-02273-1.
6
Beneficial Effects of Macroporous Resin Extract of Leaves in Rats with Hyperuricemia Induced by a High-Purine Diet.高嘌呤饮食诱导的高尿酸血症大鼠中树叶大孔树脂提取物的有益作用
Evid Based Complement Alternat Med. 2020 Feb 3;2020:3086106. doi: 10.1155/2020/3086106. eCollection 2020.
7
Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort.利尿剂对痛风患者降尿酸治疗的影响:一项起始队列分析。
Arthritis Res Ther. 2018 Mar 22;20(1):53. doi: 10.1186/s13075-018-1559-2.
8
Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials.用于预防心血管事件的黄嘌呤氧化酶抑制剂:一项随机对照试验的系统评价和荟萃分析
BMC Cardiovasc Disord. 2018 Feb 7;18(1):24. doi: 10.1186/s12872-018-0757-9.
9
The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool.利尿剂的使用和 ABCG2 基因型对已发表别嘌醇剂量工具预测性能的影响。
Br J Clin Pharmacol. 2018 May;84(5):937-943. doi: 10.1111/bcp.13516. Epub 2018 Feb 20.
10
Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study.基因变异对呋塞米治疗反应中肾脏尿酸处理的影响:一项急性干预研究。
RMD Open. 2017 Apr 11;3(1):e000424. doi: 10.1136/rmdopen-2016-000424. eCollection 2017.